# Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

> **NCT00698646** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 384 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Valsartan + HCTZ
- **DRUG:** Valsartan
- **DRUG:** HCTZ

## Key facts

- **NCT ID:** NCT00698646
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 384 (ACTUAL)
- **Last updated:** 2011-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00698646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00698646, "Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00698646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*